June 10, 2019
GBT
GBT Awards More than $200,000 in Grants to Five Nonprofit Organizations through New ACCEL Program Aimed at Improving Access to Healthcare for People Living with Sickle Cell Disease
June 10, 2019
Sesen Bio
Sesen Bio Announces Successful Pre-BLA Meeting with FDA for Vicinium®
June 10, 2019
Zafgen
Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific Sessions
June 07, 2019
Sesen Bio
Dr. Thomas Cannell, President and CEO of Sesen Bio, to Host Conference Call to Provide Regulatory Update on Pre-BLA Meeting for Vicinium®